TREA

90867023 - COSMX

Follow

Information

  • Trademark
  • 90867023
  • Serial Number
    90867023
  • Registration Number
    7530882
  • Filing Date
    August 05, 2021
    3 years ago
  • Registration Date
    October 08, 2024
    3 months ago
  • Transaction Date
    October 08, 2024
    3 months ago
  • Status Date
    October 08, 2024
    3 months ago
  • Published for Opposition Date
    May 30, 2023
    a year ago
  • Location Date
    September 04, 2024
    4 months ago
  • First Use Anywhere Date
    November 09, 2021
    3 years ago
  • First Use In Commerce Date
    November 09, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BARREDA, AMBER
  • Attorney Docket Number
    31353-TM1049
    Attorney Name
    Alyssa M. Worsham
    Law Office Assigned Location Code
    L30
  • Owners
Information
Mark Drawing Code
4
Mark Identification
COSMX
Case File Statements
  • GS0091: Automated apparatus in the nature of automated laboratory equipment, namely, computer and networking hardware, and computer systems comprised of computer hardware and downloadable computer software for detection and analysis of biomolecules for scientific use; automated apparatus in the nature of automated laboratory equipment, namely, computer and networking hardware and computer systems comprised of computer hardware and downloadable computer software for scientific research, namely, for detecting, collecting and processing optical signals and images, into data for use in the analysis of biomolecules in connection with scientific and medical research; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, namely, apparatus for recording, transmission and reproduction of images, digital signage display panels, microscopes, robotics in the nature of laboratory robots, fluidic stations in the nature of automatic fluid-composition control machines and instruments, and computer systems comprised of computer hardware and downloadable computer software for staining and visualization of tissue and cell based samples for diagnostic and scientific use; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, namely, apparatus for recording, transmission and reproduction of images, digital signage display panels, microscopes, robotics in the nature of laboratory robots and computer systems comprised of computer hardware and downloadable computer software for digitizing images of biological tissue for use in connection with pathology; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, namely, apparatus for recording, transmission and reproduction of images, digital signage display panels, microscopes, robotics in the nature of laboratory robots, and computer systems comprised of computer hardware and downloadable computer software for capturing digital images of microscope slides of biological tissue, storage of digitized microscope slide images in a data storage area, and display of digitized microscope slide images; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, namely, apparatus for recording, transmission and reproduction of images, digital signage display panels, microscopes, robotics in the nature of laboratory robots, fluidic stations in the nature of automatic fluid-composition control machines and instruments, and computer systems comprised of computer hardware and downloadable computer software for detection and analysis of, pathology, gene expression, RNA transcription, RNA translation and nucleic acid sequencing; computer hardware and downloadable computer software to enable pathologists to diagnose disease; computer hardware and downloadable computer software for the electronic scanning of clinical pathology slides; computer hardware and downloadable computer software for pathologists to render and report diagnoses and results of scientific research; computer hardware and downloadable computer software for scientific and research uses in the fields of pathology, immunohistochemistry, in situhybridization, proteomics, RNA transcription and microRNA expression profiling and nucleic acid sequencing; computer hardware and downloadable computer software for digitizing, processing and storing images of biological tissues and cells; computer hardware and downloadable computer software for analyzing the results of tissues and cell based samples obtained through operation of tissue and cell sample staining and visualization apparatus; computer hardware and downloadable computer software for identifying and diagnosing cancer and other diseases and processing digital images; computer hardware and downloadable computer software for viewing, analyzing, managing, reporting, and archiving digital images; laboratory equipment for sample preparation, mixing, hybridization, incubation, washing, location and imaging, namely, robotic equipment, fluid mixers, pumps, valves, and containers, reagent holders, sample containers and microfluidic devices, optical devices, scanning microscopes, fluorescent microscopes, digital micromirror devices, electromagnetic sensors and replacement parts therefor in the fields of scientific research; downloadable computer application software for computer systems, namely, software and data files, namely, csv, TIF, png, JPEG, and fth files to acquire, analyze, manage and report biological information
  • GS0051: Diagnostic reagents, namely, assays for medical and veterinary use in the fields of pathology, immunohistochemistry, in situhybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; diagnostic reagents for medical and veterinary use in the fields of cancer, neurology and infectious disease; diagnostic reagent kits comprising primarily of diagnostic reagents for medical and veterinary use in the fields of cancer, neurology and infectious disease; chemical reagents for medical use; reagents for medical and veterinary use containing antibodies and nucleic acids; diagnostic test kits for medical use comprising primarily of reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical and veterinary diagnostic kits comprising primarily of medical and veterinary diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; diagnostic preparations in the nature of antibodies, for medical and veterinary purposes; reagents and diagnostic reagents for medical and veterinary purposes; diagnostic preparations in the nature of in situ hybridization probes, for medical and veterinary purposes; medical and veterinary diagnostic reagents for pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; multiparameter quantitative detection and analysis products, namely, reagents and assays for medical diagnostics for a variety of uses in health care, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; medical diagnostic reagents and assays for testing of body fluids and tissue; diagnostic reagent kits consisting primarily of medical and veterinary diagnostic reagents and assays for testing of body fluids and tissue; reagents in the form of cell markers and molecule markers including antibodies and nucleic acids for medical and veterinary purposes; medical diagnostic reagents for use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; medical diagnostic reagents for use relating to molecular identification and digital quantification; medical diagnostic reagents containing antibodies and nucleic acids; medical diagnostic reagents for use in the fields of cancer, neurology and infectious disease; medical diagnostic reagents for immuno-histochemistry detection and in situhybridization detection
  • GS0011: Reagents, namely, assays for scientific research and non-medical and non-veterinary diagnostic use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; diagnostic reagents for scientific and research use in the fields of cancer, neurology and infectious disease; reagents for scientific research and non-medical and non-veterinary diagnostic use relating to molecular identification and digital quantification; reagents for scientific research and non-medical and non-veterinary diagnostic use containing antibodies and nucleic acids; reagent kits comprising primarily reagents for scientific research and non-medical and non-veterinary diagnostic use in the fields of cancer, neurology and infectious disease; reagents for immunohistochemistry detection and in situhybridization detection for scientific research and non-medical and non-veterinary diagnostic use; chemical test kits for scientific research and non-medical and non-veterinary diagnostic use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor; chemical test kits comprising reagents for scientific research and non-medical and non-veterinary diagnostic use relating to molecular identification and digital quantification; reagents for in vitro use in clinical chemistry and molecular biology; reagents for clinical and medical laboratory use, namely, reagents for pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling, nucleic acid sequencing, and clinical, oncology, neurology, and infectious disease diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific and research uses, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; chemical test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers
  • GS0101: Clinical and medical diagnostic instruments, namely, spatial molecular imagers, namely, devices for the detection, visualization and analysis of biological molecules at cellular and subcellular resolution; clinical and medical diagnostic instruments, namely, histopathology instruments and nucleic acid sequencers; clinical and medical diagnostic instruments for analysis of tissue and cell based samples, all for medical purposes; clinical and medical diagnostic instruments for performing immunohistochemistry and in situ-hybridization staining reactions, histological and pathological staining and image processing and analysis; histopathology instruments for clinical purposes; clinical and medical diagnostic instruments for immunohistochemistry and in situ-hybridization analyses; clinical and medical diagnostic instruments for the electronic scanning of clinical pathology slides, processing and storing images of biological tissues and cells and digitizing, processing and storing images of biological tissues and cells
  • GS0421: research and product development services for others in the field of biotechnology; medical and scientific research services for others in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research services for others in the field of infectious disease; medical and scientific research services for others in the field of neurology; medical and scientific research services for others, namely, research and design in the field of testing, analyzing and examining biological samples, medical samples, and cell samples; providing laboratory research services for others in the field of gene expression and genetic data mining; research and development services for others for acquiring, analyzing, and managing biological and genetic information in the fields of forensics, medicine, genetics, and environment; Scientific research, design, and development services, for others, of single-cell imaging products for acquiring, analyzing, and managing diagnostic reagents, compounds and devices, measuring apparatus for use in product research and development, separation processes, data acquisition, analysis, management and reporting of biological information in the fields of healthcare, pathology, immunohistochemistry, in situhybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing
Case File Event Statements
  • 8/9/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/30/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/4/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/12/2022 - 2 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 5/12/2022 - 2 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/12/2022 - 2 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/12/2022 - 2 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/28/2022 - 2 years ago
    8 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/28/2022 - 2 years ago
    9 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/28/2022 - 2 years ago
    10 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/24/2022 - 2 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/24/2022 - 2 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/25/2022 - 2 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/13/2023 - a year ago
    14 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/13/2023 - a year ago
    15 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/13/2023 - a year ago
    16 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/17/2023 - a year ago
    17 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/17/2023 - a year ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/18/2023 - a year ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/13/2023 - a year ago
    20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/13/2023 - a year ago
    21 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/13/2023 - a year ago
    22 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/13/2023 - a year ago
    23 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/25/2023 - a year ago
    24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/10/2023 - a year ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/30/2023 - a year ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/30/2023 - a year ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/14/2023 - a year ago
    31 - USE AMENDMENT FILED Type: IUAF
  • 12/14/2023 - a year ago
    29 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 1/5/2024 - a year ago
    30 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 7/25/2023 - a year ago
    28 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/6/2024 - a year ago
    32 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 2/6/2024 - 11 months ago
    33 - SU - NON-FINAL ACTION - WRITTEN Type: CNRT
  • 2/6/2024 - 11 months ago
    34 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/6/2024 - 11 months ago
    35 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/20/2024 - 7 months ago
    37 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 9/4/2024 - 4 months ago
    40 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/4/2024 - 4 months ago
    41 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/4/2024 - 4 months ago
    43 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 9/4/2024 - 4 months ago
    42 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 9/4/2024 - 4 months ago
    39 - ASSIGNED TO LIE Type: ALIE
  • 10/8/2024 - 3 months ago
    44 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/8/2024 - 3 months ago
    45 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 7/4/2024 - 6 months ago
    38 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 4/5/2024 - 9 months ago
    36 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA